CA
NZ
UK
AU
IND
US
…
CompuMed, Inc. provides diagnostic telemedicine solutions in the United States. It offers a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including echocardiogram, ECG/EKG, nuclear cardiology, cardiac CT and MRI, MUGA scan, cardiac catheterization, pediatric, stress testing, and holter/event monitor; and teleradiology reading and interpretation services, such as X-ray, ultrasound, chest CT, MRI, measurement, and on demand consult. The company also provides telepathology reading and interpretation services for liver, renal/kidney, pancreas, and tissue; and pulmonology reading and interpretation services comprising bronchoscopy, 3D rendering, measurement, and lung management. In addition, it provides support services; and operates CompuMed, a cloud-based portal that allows to view, manage, and share your case data. The company serves organ donation/transplant, correctional healthcare, hospitals, and rural hospital telemedicine medicines. CompuMed, Inc. was incorporated in 1986 and is headquartered in Los Angeles, California.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on CompuMed Inc (CMPD) on the OTC Pink market is limited, so its operations and product mix are not clearly disclosed. Documented long-term growth drivers are unavailable and would depend on execution, capital access, and any future strategic disclosures. Some investors may view it as speculative microcap exposure that could benefit from improved disclosure or a turnaround.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
| Income before tax | -0.04M | 0.20M | -0.01M | 0.51M | 1.07M |
| Net income | -0.06M | 0.19M | -0.03M | 0.50M | 1.07M |
| Gross profit | 3.58M | 3.02M | 2.89M | 3.30M | 3.35M |
| Ebit | 0.02M | 0.24M | 0.01M | 0.55M | 1.13M |
| Ebitda | 0.81M | 0.95M | 0.69M | 1.12M | 1.48M |
| Depreciation and amortization | 0.79M | 0.72M | 0.68M | 0.57M | 0.35M |
| Operating income | -0.02M | 0.20M | -0.03M | 0.55M | 1.01M |
| Other operating expenses | 7.56M | 6.02M | 5.87M | 5.81M | 5.30M |
| Interest expense | 0.06M | 0.04M | 0.03M | 0.04M | 0.06M |
| Income tax expense | 0.02M | 0.00M | 0.02M | 0.01M | 0.00M |
| Total revenue | 7.55M | 6.22M | 5.84M | 6.37M | 6.32M |
| Total operating expenses | 3.60M | 2.82M | 2.92M | 2.75M | 2.33M |
| Cost of revenue | 3.97M | 3.20M | 2.95M | 3.06M | 2.97M |
| Total other income expense net | -0.03M | -0.01M | 0.02M | -0.04M | 0.06M |
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
| Total assets | 5.01M | 4.62M | 4.44M | 5.35M | 5.13M |
| Intangible assets | 0.28M | 0.48M | 0.68M | - | - |
| Other current assets | 0.17M | 0.18M | 0.20M | 0.18M | 0.11M |
| Total liab | 1.91M | 1.34M | 1.35M | 1.50M | 1.77M |
| Total stockholder equity | 3.10M | 3.28M | 3.09M | 3.85M | 3.36M |
| Other current liab | 0.78M | 0.55M | 0.53M | 0.53M | 0.75M |
| Common stock | 0.42M | 0.42M | 0.42M | 0.42M | 0.41M |
| Retained earnings | -33.96M | -33.89M | -34.08M | -34.05M | -34.54M |
| Other assets | - | - | 0.00M | 0.00M | 0.00M |
| Cash | 1.65M | 1.56M | 1.08M | 1.80M | 2.21M |
| Total current liabilities | 1.42M | 1.02M | 1.18M | 1.20M | 1.23M |
| Net debt | -0.94M | -1.04M | -0.69M | -1.26M | -1.45M |
| Short term debt | 0.23M | 0.20M | 0.23M | 0.24M | 0.23M |
| Short long term debt total | 0.71M | 0.52M | 0.39M | 0.54M | 0.76M |
| Other stockholder equity | 36.64M | 36.76M | 36.76M | 37.48M | 37.49M |
| Total current assets | 2.91M | 2.96M | 2.58M | 3.17M | 3.33M |
| Net receivables | 1.05M | 0.99M | 0.90M | 1.06M | 0.85M |
| Inventory | 0.04M | 0.23M | 0.40M | 0.14M | 0.15M |
| Accounts payable | 0.42M | 0.27M | 0.43M | 0.43M | 0.26M |
| Non currrent assets other | 0.00M | 0.01M | 0.00M | 0.82M | 0.00M |
| Non current assets total | 2.10M | 1.66M | 1.86M | 2.18M | 1.80M |
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
| Total cashflows from investing activities | -1.23M | -0.52M | -0.37M | -0.91M | -0.88M |
| Total cash from financing activities | 0.07M | 0.13M | -0.87M | -0.24M | -0.22M |
| Net income | -0.06M | 0.19M | -0.03M | 0.50M | 1.07M |
| Change in cash | 0.09M | 0.48M | -0.72M | -0.41M | 0.32M |
| Begin period cash flow | 1.56M | 1.08M | 1.80M | 2.21M | 1.89M |
| End period cash flow | 1.65M | 1.56M | 1.08M | 1.80M | 2.21M |
| Total cash from operating activities | 1.25M | 0.88M | 0.52M | 0.74M | 1.42M |
| Depreciation | 0.79M | 0.72M | 0.68M | 0.57M | 0.35M |
| Change to account receivables | -0.06M | -0.09M | 0.16M | -0.20M | -0.06M |
| Sale purchase of stock | -0.13M | - | -0.72M | -0.01M | - |
| Other cashflows from financing activities | - | - | -0.37M | -0.91M | -0.22M |
| Capital expenditures | 1.23M | 0.52M | 0.37M | 0.91M | 0.88M |
| Change in working capital | 0.52M | -0.03M | -0.13M | -0.31M | 0.10M |
| Other non cash items | - | -0.00M | -0.00M | -0.02M | -0.10M |
| Free cash flow | 0.02M | 0.36M | 0.15M | -0.17M | 0.54M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CMPD CompuMed Inc |
-0.01 0.17% |
5.99 | - | - | 5.14 | 36.30 | 2.45 | -21.01 |
| VEEV Veeva Systems Inc Class A |
2.62 0.84% |
312.96 | 43.49 | 29.59 | 12.48 | 5.79 | 10.39 | 33.41 |
| PMCUF Pro Medicus Limited |
- -% |
137.03 | 64.90 | 90.91 | 49.11 | 38.05 | 65.12 | 83.47 |
| TEM Tempus AI, Inc. Class A Common Stock |
-5.62 7.22% |
72.22 | - | - | 8.68 | 25.39 | 8.33 | - |
| MTHRY M3 Inc |
-0.03 0.52% |
5.77 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
CompuMed, Inc. provides diagnostic telemedicine solutions in the United States. It offers a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including echocardiogram, ECG/EKG, nuclear cardiology, cardiac CT and MRI, MUGA scan, cardiac catheterization, pediatric, stress testing, and holter/event monitor; and teleradiology reading and interpretation services, such as X-ray, ultrasound, chest CT, MRI, measurement, and on demand consult. The company also provides telepathology reading and interpretation services for liver, renal/kidney, pancreas, and tissue; and pulmonology reading and interpretation services comprising bronchoscopy, 3D rendering, measurement, and lung management. In addition, it provides support services; and operates CompuMed, a cloud-based portal that allows to view, manage, and share your case data. The company serves organ donation/transplant, correctional healthcare, hospitals, and rural hospital telemedicine medicines. CompuMed, Inc. was incorporated in 1986 and is headquartered in Los Angeles, California.
5777 West Century Blvd., Los Angeles, CA, United States, 90045
310 258 5000
8
| Name | Title | Year Born |
|---|---|---|
| Mr. Lee Keddie | CEO, Pres & Director | NA |
| Ms. Laura Carroll | CFO & Sec. | NA |
| Mr. Lee Keddie | CEO, President & Director | NA |
| Ms. Laura Carroll | CFO, Secretary & Director | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.82%
Communication Services
-0.22%
Consumer Cyclical
-0.13%
Consumer Defensive
+0.32%
Energy
+0.15%
Financial Services
-0.85%
Financials
+2.34%
Healthcare
-1.28%
Industrials
-0.96%
Real Estate
-0.38%
Technology
-2.73%
Utilities
-0.31%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...